Three-Year Continuation Rate of Etonogestrel Subnormal Implant and Associated Factors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20180405003

Enrollment

620

Registered

2018-04-05

Start date

2017-05-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Need contraception Etonogestrel Subdermal contraceptive implant Long&#45

Interventions

Health Services Research

Contraceptive implants uesd

Women who had the contraceptive implants inserted between 1 Jan 2014 to 30 April 2015

Eligibility

Sex/Gender

Female

Age

10 Years to 49 Years

Inclusion criteria

Inclusion criteria: Women who had the contraceptive implants inserted between 1 Jan 2014 to 30 April 2015 at the family planning clinic and inpatient department of Ramathibodi Hospital

Exclusion criteria

Exclusion criteria: Using the implants for non-contraceptive indication No documentation of baseline data on medical record

Design outcomes

Primary

Measure	Time frame
Continuation rate of subdermal contraceptive implant at 3 years after insertion Month of contraceptive used	—

Secondary

Measure	Time frame
Factors that associated with continuation at time of removal Patient factor,Reason of discontinuation at time of removal Adverse effect or reasons	—

Countries

Thailand

Contacts

Public ContactNicha Assavapokee

Ramathibodi Hospital

kunniinii@gmail.com0830601001

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Three&#45;Year Continuation Rate of Etonogestrel Subnormal Implant and Associated Factors